TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Fisher, Bonadonna Studies Still Fuel DeVita’s Optimism; Carbon Lists Six Basic Research Needs July 15, 1977
TCL Archive Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session November 16, 2012
TCL Archive NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted. June 20, 2003
